What the Repatha TV commercial - On the Right Path is about.
Repatha is a drug used to treat high cholesterol levels in the blood. In the Repatha TV spot, 'On the Right Path,' the drug is marketed as a solution to help people get their cholesterol levels under control. The ad features a diverse group of people, all of whom have different lifestyles and risk factors for high cholesterol.
The opening shot shows a woman walking her dog, and the ad then moves into scenes depicting different people going about their daily routines. There's a man climbing stairs to get to his apartment, a woman taking her bike for a ride, and a man enjoying a round of golf. Each person is shown taking positive steps to manage their health, and the message is that using Repatha is just one more step on the path to good health.
The voiceover tells viewers that with Repatha, they can lower their cholesterol levels by up to 60%, which is a significant reduction. The ad emphasizes that the drug is for people who are already making healthy choices but need a little extra help. The ultimate message is that being on the right path means taking ownership of your health, including using medications like Repatha when necessary.
Overall, the Repatha TV spot is well-produced and provides a clear message about the benefits of the drug. It's likely to be effective in convincing people who are already interested in managing their cholesterol to talk to their doctor about whether Repatha might be right for them.
Repatha TV commercial - On the Right Path produced for
Repatha
was first shown on television on December 7, 2017.
Frequently Asked Questions about repatha tv spot, 'on the right path'
Repatha. Repatha's marketing strategy is focused on promoting the updated findings on its extended usage to reduce total cardiovascular events.
Repatha® is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery.
Repatha ® helps the liver clear LDL cholesterol by limiting the actions of a protein called PCSK9 - and less PCSK9 means less LDL-C in the blood.
Repatha is a medicine that is designed to be taken long term to reduce the risk of cardiovascular disease. Repatha works while you are using Repatha so if you stop taking Repatha, and once all of the Repatha has left your body, then it will stop having its beneficial effect.
Repatha® is for people with an inherited condition that causes high bad cholesterol (called familial hypercholesterolemia, or FH), who still need to lower their bad cholesterol with diet, alone or together with other cholesterol-lowering medicines.
Repatha ® offers your patients the flexibility of a single monthly injection or an injection every 2 weeks. Consider the SureClick ® autoinjector for patients who are comfortable self-injecting with a hand-held device.
The recommended dosage of REPATHA is either 140 mg every 2 weeks OR 420 mg once monthly administered subcutaneously [see Dosage and Administration (2.3)]. If switching dosage regimens, administer the first dose of the new regimen on the next scheduled date of the prior regimen.
Repatha® is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery.
Official answer. You can inject Repatha at any time of the day, but usually people prefer injecting Repatha during daylight hours because it takes 30 to 45 minutes for it to warm up to room temperature, and you need to be able to easily see what you are doing while you are injecting it.
Repatha is a medicine that is designed to be taken long term to reduce the risk of cardiovascular disease. Repatha works while you are using Repatha so if you stop taking Repatha, and once all of the Repatha has left your body, then it will stop having its beneficial effect.
You can use your thigh; stomach (abdomen), except for a two-inch area around your belly button; outer area of upper arm (outer arm only if someone else is giving you the injection). Do not inject into areas where the skin is tender, bruised, red, or hard.
o The initial recommended dosage of REPATHA is 420 mg once monthly administered subcutaneously [see Dosage and Administration (2.3)]. o The dosage can be increased to 420 mg every 2 weeks if a clinically meaningful response is not achieved in 12 weeks.